Background/Aims
To analyze the usefulness of hepatic venous pressure gradient (HVPG) in
survival prediction in cirrhotic patients with early and very early hepatocellular carcinoma (HCC).
Methods
We consecutively collected data of 45 stable cirrhotic patients (male 41, median
age 57.2 years, BCLC A 29) with early-stage HCC undergoing HVPG measurement. Prognostic
accuracy of HVPG was analyzed by the area under curve (AUC). Survival curves and the
associated factors of HVPG status were obtained using Kaplan-Meier method and logistic
regression analysis, respectively.
Results
The AUC value for prediction of survival by HVPG were 0.754 (95% CI, 0.603-0.870,
P=0.006). The cut-off value of HVPG to predict death was 12 mmHg. Among the 45 patients,
11 patients (24.4%) died: 11 of 28 patients in the high HVPG group and none of 17 patients in the
low HVPG group during followup period (P=0.003). The survival rate with high HVPG group was
higher than those of low HVPG group (log rank P=0.008). In Child-Turcott-Pugh (CTP) class, the
survival rate with CTP A class was higher than that with CTP B class (log rank P<0.001). The only
associated factor with HVPG ≥12 mmHg in CTP A class and early-stage HCC was the presence
of medium or large sized esophageal varices (odds ratio 66.8, 95% CI, 1.3-3530.4, P=0.038).
Conclusions
HVPG ≥12 mmHg may be suggested a predictor of survival in cirrhotic patients
with early-stage HCC. In CTP A class, the presence of medium or large sized esophageal varices
were associated with high HVPG.